Molecular Targeting Probes - Radioactive & Nonradioactive -> Novel Radiochemistry & Chelation 583

583 - Nucleophilic radiofluorination of aryl halides with K18F mediated by well-defined copper complexes (ID 1242)

Session Name
New Radiochemistry Methodology
Speakers
Authors
Presentation Topic
Molecular Targeting Probes - Radioactive & Nonradioactive -> Novel Radiochemistry & Chelation
Presentation Number
583

Previous Eposter
581 - N-(Maleimidoethyl)-3-(guanidinomethyl)-5-[131I]iodobenzmide ([131I]MEGMIB): A Residualizing Prosthetic Agent for Site-Specific Radioiodination of Internalizing Single Domain Antibody Fragments. (ID 1243)

Next Eposters
585 - 18F-Radiofluorination of Aryl C-H Bonds using a Tandem Ir C-H Borylation/Cu Radiofluorination Strategy (ID 1241)
586 - A general 11C-carboxylation approach mediated by fluoride-desilylation of organosilanes (ID 1239)
587 - MACROPA highly stable chelator of Radium-223 and functionalization attempts for targeted treatment of cancer (ID 1246)
588 - 177Lu-EB-PSMA radioligand therapy with escalating doses in patients with metastatic castration-resistant prostate cancer (ID 771)
590 - Interim Assessment of Kidney Dosimetry and Pharmacokinetics in a Phase I Study of CTT1403, a novel 177Lu-labeled Small Molecule Inhibitor of Prostate Specific Membrane Antigen (ID 773)
591 - Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer (ID 775)
593 - Predictive factors and prediction nomograms for LuPSMA radioligand therapy in patients with metastatic castration-resistant prostate cancer: an international multicentre retrospective study (ID 777)
594 - Hematotoxicity after Radioligand Therapy with 177Lu-PSMA-617 in Patients with Metastastic Prostate Cancer (ID 776)
595 - PSMA-ligand uptake in posttherapeutic 177Lu-PSMA-617 scintigraphy to predict PSA response in patients with advanced mCRPC (ID 778)
598 - Bridging brain structural/functional connectivity and tau load in PSP: A [18F]PI-2620 PET/MRI study (ID 855)